Cinética y capacidad neutralizante de los anticuerpos homólogos y ...

Referencias Bibliográficas
142. Kurane I, Ennis FE. Immunity and immunopathology in dengue virus infections.
Semin Immunol 1992;4(2):121-7.
143. Markoff L, Chang A, Falgout B, Sithiprasasna R, Strickman D, Innis BL, et al.
Processing of Flavivirus Structural Glycoproteins: Stable Membrane Insertion of
Premembrane Requires the Envelope Signal Peptide
ELISA for detecting dengue and Japanese encephalitis viral antigen in mosquitoes.
Virology 1994;204(2):526-540.
144. Kurane I, Meager A, Ennis FA. Induction of interferon alpha and gamma from
human lymphocytes by dengue virus-infected cells. J Gen Virol 1986;67 ( Pt 8):1653-61.
145. Bielefeldt Ohmann H, Beasley DW, Fitzpatrick DR, Aaskov JG. Analysis of a
recombinant dengue-2 virus-dengue-3 virus hybrid envelope protein expressed in a
secretory baculovirus system. J Gen Virol 1997;78(Pt 11):2723-33.
146. Kulkarni AB, Mullbacher A, Parrish CR, Westaway EG, Coia G, Blanden RV.
Analysis of murine major histocompatibility complex class II-restricted T-cell responses to
the flavivirus Kunjin by using vaccinia virus expression. J Virol 1992;66(6):3583-92.
147. Bielefeldt-Ohmann H, Beasley DW, Fitzpatrick DR, Aaskov JG. Analysis of a
recombinant dengue-2 virus-dengue-3 virus hybrid envelope protein expressed in a
secretory baculovirus system. J Gen Virol 1997;78 ( Pt 11):2723-33.
148. Gagnon SJ, Ennis FA, Rothman AL. Bystander target cell lysis and cytokine
production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J Virol
1999;73(5):3623-9.
149. Livingston PG, Toomey S, Kurane I, Janus J, Ennis FA. Modulation of the
functions of dengue virus-specific human CD8+ cytotoxic T cell clone by IL-2, IL-7 and
IFN gamma. Immunol Invest 1995;24(4):619-29.
150. Juffrie M, van Der Meer GM, Hack CE, Haasnoot K, Sutaryo, Veerman AJ, et al.
Inflammatory mediators in dengue virus infection in children: interleukin-8 and its
relationship to neutrophil degranulation. Infect Immun 2000;68(2):702-7.
151. Yang KD, Wang CL, Shaio MF. Production of cytokines and platelet activating
factor in secondary dengue virus infections. J Infect Dis 1995;172(2):604-5.
152. Lin CF, Lei HY, Liu CC, Liu HS, Yeh TM, Wang ST, et al. Generation of IgM antiplatelet
autoantibody in dengue patients. J Med Virol 2001;63(2):143-9.
153. Isarangkura P, Tuchinda S. The behavior of transfused platelets in dengue
hemorrhagic fever. Southeast Asian J Trop Med Public Health 1993;24 Suppl 1:222-4.
154. Halstead SB. Etiologies of the experimental dengues of Siler and Simmons. Am J
Trop Med Hyg 1974;23(5):974-82.
155. Okuno Y, Fukunaga T, Tadano M, Fukai K, Ikeda T, Sekii K, et al. Serological
studies on volunteers inoculated experimentally with a dengue virus strain in 1943. Biken J
1983;26(4):161-3.
156. Innis BL, Thirawuth V, Hemachudha C. Identification of continuous epitopes of the
envelope glycoprotein of dengue type 2 virus. Am J Trop Med Hyg 1989;40(6):676-87.
157. Vazquez S, Perez AB, Ruiz D, Rodriguez R, Pupo M, Calzada N, et al. Serological
markers during dengue 3 primary and secondary infections. J Clin Virol 2005;33(2):132-7.
158. Summers PL, Eckels KH, Dalrymple JM, Scott RM, Boyd VA. Antibody response
to dengue-2 vaccine measured by two different radioimmunoassay methods. J Clin
Microbiol 1984;19(5):651-9.
129